Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease

References

• Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019;322(16):1589–1599. doi:10.1001/jama.2019.4782
   PubMed Web of Science ®Google Scholar
• Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483–491. doi:10.1016/j.jalz.2017.12.006
   PubMed Web of Science ®Google Scholar
• Srivastava P, Tripathi PN, Sharma P, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur J Med Chem. 2019;163:116–135. doi:10.1016/j.ejmech.2018.11.049
   PubMed Web of Science ®Google Scholar
• Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem. 2019;85:82–96. doi:10.1016/j.bioorg.2018.12.017
   PubMed Web of Science ®Google Scholar
• Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179(2):312–339. doi:10.1016/j.cell.2019.09.001
   PubMed Web of Science ®Google Scholar
• Rai SN, Singh C, Singh A, Singh MP, Singh BK. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease. Mol Neurobiol. 2020;57(7):3075–3088. doi:10.1007/s12035-020-01945-y
   PubMed Web of Science ®Google Scholar
• Kloske CM, Wilcock DM. The Important interface between apolipoprotein E and neuroinflammation in Alzheimer’s disease. Front Immunol. 2020;11:754. doi:10.3389/fimmu.2020.00754
   PubMed Web of Science ®Google Scholar
• Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441–468. doi:10.1146/annurev-immunol-051116-052358
   PubMed Web of Science ®Google Scholar
• Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359–1369. doi:10.1038/s41593-018-0242-x
   PubMed Web of Science ®Google Scholar
• Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42. doi:10.1186/s40035-020-00221-2
   PubMed Web of Science ®Google Scholar
• Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s disease. J Cell Biol. 2018;217(2):459–472. doi:10.1083/jcb.201709069
   PubMed Web of Science ®Google Scholar
• Frost JL, Schafer DP. Microglia: Architects of the Developing Nervous System. Trends Cell Biol. 2016;26(8):587–597. doi:10.1016/j.tcb.2016.02.006
   PubMed Web of Science ®Google Scholar
• Gaire BP. Microglia as the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia. Cell Mol Neurobiol. 2022;42(8):2505–2525. doi:10.1007/s10571-021-01145-9
   PubMed Web of Science ®Google Scholar
• Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57–69. doi:10.1038/nrn2038
   PubMed Web of Science ®Google Scholar
• Lavisse S, Goutal S, Wimberley C, et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021;82:29–36. doi:10.1016/j.parkreldis.2020.11.011
   PubMed Web of Science ®Google Scholar
• Bairamian D, Sha S, Rolhion N, et al. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease. Mol Neurodegener. 2022;17(1):19. doi:10.1186/s13024-022-00522-2
   PubMed Web of Science ®Google Scholar
• Shen H, He Z, Pei H, Zhai L, Guan Q, Wang G. Aurantiamide promotes M2 polarization of microglial cells to improve the cognitive ability of mice with Alzheimer’s disease. Phytother Res. 2023;37(1):101–110. doi:10.1002/ptr.7597
   PubMed Web of Science ®Google Scholar
• Tang Y, Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2016;53(2):1181–1194. doi:10.1007/s12035-014-9070-5
   PubMed Web of Science ®Google Scholar
• Xie L, Liu Y, Zhang N, et al. Electroacupuncture Improves M2 Microglia Polarization and Glia Anti-inflammation of Hippocampus in Alzheimer’s Disease. Front Neurosci. 2021;15:689629. doi:10.3389/fnins.2021.689629
   PubMed Web of Science ®Google Scholar
• Jha MK, Lee WH, Suk K. Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders. Biochem Pharmacol. 2016;103:1–16. doi:10.1016/j.bcp.2015.11.003
   PubMed Web of Science ®Google Scholar
• Saito T, Saido TC. Neuroinflammation in mouse models of Alzheimer’s disease. Clin Exp Neuroimmunol. 2018;9(4):211–218. doi:10.1111/cen3.12475
   PubMedGoogle Scholar
• Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918–934. doi:10.1016/j.cell.2010.02.016
   PubMed Web of Science ®Google Scholar
• Gupta N, Shyamasundar S, Patnala R, et al. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies. Expert Opin Ther Targets. 2018;22(9):765–781. doi:10.1080/14728222.2018.1515917
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu B, Yang LE, Zhang C. Platycodigenin as Potential Drug Candidate for Alzheimer’s Disease via Modulating Microglial Polarization and Neurite Regeneration. Molecules. 2019;24(18). doi:10.3390/molecules24183207
   Web of Science ®Google Scholar
• Yao K, Zu HB. Microglial polarization: novel therapeutic mechanism against Alzheimer’s disease. Inflammopharmacology. 2020;28(1):95–110. doi:10.1007/s10787-019-00613-5
   PubMed Web of Science ®Google Scholar
• Rai SN, Chaturvedi VK, Singh BK, Singh MP. Commentary: Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer’s Mouse Model. Front Aging Neurosci. 2020;12:219. doi:10.3389/fnagi.2020.00219
   PubMed Web of Science ®Google Scholar
• Ruganzu JB, Zheng Q, Wu X, et al.. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway. Exp Neurol. 2020:113506. doi:10.1016/j.expneurol.2020.113506
   PubMed Web of Science ®Google Scholar
• Xu Q, Xu W, Cheng H, Yuan H, Tan X. Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2. Brain Behav Immun. 2019;81:495–508. doi:10.1016/j.bbi.2019.07.004
   PubMed Web of Science ®Google Scholar
• Gaojian T, Dingfei Q, Linwei L, et al. Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway. Cell Death Discov. 2020;6(1):97. doi:10.1038/s41420-020-00333-8
   PubMed Web of Science ®Google Scholar
• Qi S, Al Mamun A, Ngwa C, et al. X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals. J Neuroinflammation. 2021;18(1):70. doi:10.1186/s12974-021-02120-3
   PubMed Web of Science ®Google Scholar
• Wu H, Zheng J, Xu S, et al. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation. 2021;18(1):2. doi:10.1186/s12974-020-02041-7
   PubMed Web of Science ®Google Scholar
• Laffer B, Bauer D, Wasmuth S, et al. Loss of IL-10 Promotes Differentiation of Microglia to a M1 Phenotype. Front Cell Neurosci. 2019;13:430. doi:10.3389/fncel.2019.00430
   PubMed Web of Science ®Google Scholar
• Liao X, Sharma N, Kapadia F, et al. Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121(7):2736–2749. doi:10.1172/JCI45444
   PubMed Web of Science ®Google Scholar
• Ji J, Wang J, Yang J, et al. The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation. Front Immunol. 2019;10:1241. doi:10.3389/fimmu.2019.01241
   PubMed Web of Science ®Google Scholar
• El-Deeb NK, El-Tanbouly DM, Khattab MA, El-Yamany MF, Mohamed AF. Crosstalk between PI3K/AKT/KLF4 signaling and microglia M1/M2 polarization as a novel mechanistic approach towards flibanserin repositioning in parkinson’s disease. Int Immunopharmacol. 2022;112:109191. doi:10.1016/j.intimp.2022.109191
   PubMed Web of Science ®Google Scholar
• Hsu CH, Pan YJ, Zheng YT, Lo RY, Yang FY. Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARγ signaling pathways. CNS Neurosci Ther. 2023. doi:10.1111/cns.14333
   PubMed Web of Science ®Google Scholar
• Dräger NM, Sattler SM, Huang CT, et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat Neurosci. 2022;25(9):1149–1162. doi:10.1038/s41593-022-01131-4
   PubMed Web of Science ®Google Scholar
• Ryan KJ, White CC, Patel K, et al. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci Transl Med. 2017;9(421). doi:10.1126/scitranslmed.aai7635
   Web of Science ®Google Scholar
• Anwar S, Rivest S. Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opin Ther Targets. 2020;24(4):331–344. doi:10.1080/14728222.2020.1738391
   PubMed Web of Science ®Google Scholar
• Lee J, Kim DE, Griffin P, et al. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer’s disease. Aging Cell. 2020;19(2):e13078. doi:10.1111/acel.13078
   PubMed Web of Science ®Google Scholar
• Parbo P, Ismail R, Hansen KV, et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease. Brain. 2017;140(7):2002–2011. doi:10.1093/brain/awx120
   PubMedGoogle Scholar
• Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease. Brain. 2015;138(Pt 12):3685–3698. doi:10.1093/brain/awv288
   PubMedGoogle Scholar
• Chiarini A, Armato U, Hu P, Dal Prà I. Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease. Int J Mol Sci. 2020;21(23). doi:10.3390/ijms21239036
   Web of Science ®Google Scholar
• Tejera D, Heneka MT. In Vivo Phagocytosis Analysis of Amyloid Beta. Methods Mol Biol. 2019;2034:287–292. doi:10.1007/978-1-4939-9658-2_21
   PubMedGoogle Scholar
• Balducci C, Frasca A, Zotti M, et al. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease. Brain Behav Immun. 2017;60:188–197. doi:10.1016/j.bbi.2016.10.012
   PubMed Web of Science ®Google Scholar
• Zusso M, Lunardi V, Franceschini D, et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. J Neuroinflammation. 2019;16(1):148. doi:10.1186/s12974-019-1538-9
   PubMed Web of Science ®Google Scholar
• Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK. Nuclear factor-kappa β as a therapeutic target for Alzheimer’s disease. J Neurochem. 2019;150(2):113–137. doi:10.1111/jnc.14687
   PubMed Web of Science ®Google Scholar
• Rai SN, Tiwari N, Singh P, et al. Therapeutic potential of vital transcription factors in Alzheimer’s and Parkinson’s disease with particular emphasis on transcription factor eb mediated autophagy. Front Neurosci. 2021;15:777347. doi:10.3389/fnins.2021.777347
   PubMed Web of Science ®Google Scholar
• Streit WJ, Xue QS, Tischer J, Bechmann I. Microglial pathology. Acta Neuropathol Commun. 2014;2:142. doi:10.1186/s40478-014-0142-6
   PubMed Web of Science ®Google Scholar
• Fu AK, Hung KW, Yuen MY, et al. IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A. 2016;113(19):E2705–E2713. doi:10.1073/pnas.1604032113
   PubMed Web of Science ®Google Scholar
• Ren C, Li D, Zhou Q, Hu X. Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer’s disease model. Biomaterials. 2020;232:119752. doi:10.1016/j.biomaterials.2019.119752
   PubMed Web of Science ®Google Scholar
• Perea JR, Llorens-Martín M, Ávila J, Bolós M. The Role of Microglia in the Spread of Tau: Relevance for Tauopathies. Front Cell Neurosci. 2018;12:172. doi:10.3389/fncel.2018.00172
   PubMed Web of Science ®Google Scholar
• Uddin MS, Lim LW. Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications. Ageing Res Rev. 2022;78:101622. doi:10.1016/j.arr.2022.101622
   PubMed Web of Science ®Google Scholar
• Zilka N, Kazmerova Z, Jadhav S, et al. Who fans the flames of Alzheimer’s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation. 2012;9:47. doi:10.1186/1742-2094-9-47
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68(1):19–31. doi:10.1016/j.neuron.2010.08.023
   PubMed Web of Science ®Google Scholar
• Maphis NM, Jiang S, Binder J, et al. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Front Mol Neurosci. 2017;10:69. doi:10.3389/fnmol.2017.00069
   PubMed Web of Science ®Google Scholar
• Maphis N, Xu G, Kokiko-Cochran ON, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138(Pt 6):1738–1755. doi:10.1093/brain/awv081
   PubMedGoogle Scholar
• Wang C, Xiong M, Gratuze M, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109(10):1657–1674.e7. doi:10.1016/j.neuron.2021.03.024
   PubMed Web of Science ®Google Scholar
• Lin G, Zhu F, Kanaan NM, et al. Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein. Int J Mol Sci. 2021;22(21). doi:10.3390/ijms222112063
   Web of Science ®Google Scholar
• Sun Y, Xiao Q, Luo C, et al. High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway. Exp Cell Res. 2017;359(2):312–318. doi:10.1016/j.yexcr.2017.07.032
   PubMed Web of Science ®Google Scholar
• Beamer E, Corrêa S. The p38MAPK-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission. Front Cell Dev Biol. 2021;9:635636. doi:10.3389/fcell.2021.635636
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang Y, Liu S, et al. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC/p38MAPK/NF-κB pathway. J Neuroinflammation. 2019;16(1):10. doi:10.1186/s12974-019-1398-3
   PubMed Web of Science ®Google Scholar
• Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179. doi:10.1038/nrd.2016.117
   PubMed Web of Science ®Google Scholar
• Idda ML, Munk R, Abdelmohsen K, Gorospe M. Noncoding RNAs in Alzheimer’s disease. Wiley Interdiscip Rev RNA. 2018;9(2). doi:10.1002/wrna.1463
   Web of Science ®Google Scholar
• Kim KW. PIWI Proteins and piRNAs in the Nervous System. Mol Cells. 2019;42(12):828–835. doi:10.14348/molcells.2019.0241
   PubMed Web of Science ®Google Scholar
• Wakisaka KT, Imai Y. The Dawn of pirna research in various neuronal disorders. Front Biosci. 2019;24(8):1440–1451. doi:10.2741/4789
   Google Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18. doi:10.1038/nrc.2017.99
   PubMed Web of Science ®Google Scholar
• Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ. Targeting noncoding RNAs in disease. J Clin Invest. 2017;127(3):761–771. doi:10.1172/JCI84424
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207. doi:10.1016/j.jaci.2017.08.034
   PubMed Web of Science ®Google Scholar
• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16(7):421–433. doi:10.1038/nrg3965
   PubMed Web of Science ®Google Scholar
• Guo Y, Hong W, Wang X, et al. MicroRNAs in Microglia: How do MicroRNAs Affect Activation, Inflammation, Polarization of Microglia and Mediate the Interaction Between Microglia and Glioma. Front Mol Neurosci. 2019;12:125. doi:10.3389/fnmol.2019.00125
   PubMed Web of Science ®Google Scholar
• Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019;20(5):1836–1852. doi:10.1093/bib/bby054
   PubMed Web of Science ®Google Scholar
• Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J Transl Med. 2016;14(1):143. doi:10.1186/s12967-016-0893-x
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–524. doi:10.1038/nrm3838
   PubMed Web of Science ®Google Scholar
• Vasudeva K, Munshi A. miRNA dysregulation in ischaemic stroke: Focus on diagnosis, prognosis, therapeutic and protective biomarkers. Eur J Neurosci. 2020;52(6):3610–3627. doi:10.1111/ejn.14695
   PubMed Web of Science ®Google Scholar
• Li B, Dasgupta C, Huang L, Meng X, Zhang L. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy. Cell Mol Immunol. 2020;17(9):976–991. doi:10.1038/s41423-019-0257-6
   PubMed Web of Science ®Google Scholar
• Gullett JM, Chen Z, O’Shea A, et al. MicroRNA predicts cognitive performance in healthy older adults. Neurobiol Aging. 2020;95:186–194. doi:10.1016/j.neurobiolaging.2020.07.023
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13(5):358–369. doi:10.1038/nrg3198
   PubMed Web of Science ®Google Scholar
• Vishnoi A, Rani S. MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol. 2017;1509:1–10. doi:10.1007/978-1-4939-6524-3_1
   PubMedGoogle Scholar
• Freilich RW, Woodbury ME, Ikezu T. Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One. 2013;8(11):e79416. doi:10.1371/journal.pone.0079416
   PubMed Web of Science ®Google Scholar
• Guedes JR, Custódia CM, Silva RJ, de Almeida LP, Pedroso de lima MC, Cardoso AL. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer’s disease triple transgenic mouse model. Hum Mol Genet. 2014;23(23):6286–6301. doi:10.1093/hmg/ddu348
   PubMed Web of Science ®Google Scholar
• Jakaria M, Haque ME, Cho DY, Azam S, Kim IS, Choi DK. Molecular insights into NR4A2(Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death. Mol Neurobiol. 2019;56(8):5799–5814. doi:10.1007/s12035-019-1487-4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu C, Nan Y, Nan S. Microglia-Derived Extracellular Vesicles Carrying miR-711 Alleviate Neurodegeneration in a Murine Alzheimer’s Disease Model by Binding to Itpkb. Front Cell Dev Biol. 2020;8:566530. doi:10.3389/fcell.2020.566530
   PubMed Web of Science ®Google Scholar
• Mishra R, Chhatbar C, Singh SK. HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia. J Neuroinflammation. 2012;9:131. doi:10.1186/1742-2094-9-131
   PubMed Web of Science ®Google Scholar
• Lv J, Zeng Y, Qian Y, Dong J, Zhang Z, Zhang J. MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial activation. Brain Res. 2018;1685:91–104. doi:10.1016/j.brainres.2018.01.032
   PubMed Web of Science ®Google Scholar
• Jia LH, Liu YN. Downregulated serum miR-223 servers as biomarker in Alzheimer’s disease. Cell Biochem Funct. 2016;34(4):233–237. doi:10.1002/cbf.3184
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou D, Ren Y, et al. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy. 2019;15(3):478–492. doi:10.1080/15548627.2018.1522467
   PubMed Web of Science ®Google Scholar
• Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis. 2020;11(4):290. doi:10.1038/s41419-020-2490-4
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang R. Deregulated lncRNA MAGI2-AS3 in Alzheimer’s disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Exp Gerontol. 2021;144:111180. doi:10.1016/j.exger.2020.111180
   PubMed Web of Science ®Google Scholar
• Liang C, Zou T, Zhang M, et al. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer’s disease. Theranostics. 2021;11(9):4103–4121. doi:10.7150/thno.53418
   PubMed Web of Science ®Google Scholar
• Kumar A, Bhatia HS, de Oliveira AC, Fiebich BL. microRNA-26a modulates inflammatory response induced by toll-like receptor 4 stimulation in microglia. J Neurochem. 2015;135(6):1189–1202. doi:10.1111/jnc.13364
   PubMed Web of Science ®Google Scholar
• Lv YN, Ou-Yang AJ, Fu LS. MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4. Cell Mol Neurobiol. 2017;37(2):195–210. doi:10.1007/s10571-016-0361-4
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang R, Lu K, et al. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice. J Neurol Sci. 2016;367:3–10. doi:10.1016/j.jns.2016.05.038
   PubMed Web of Science ®Google Scholar
• Wei Z, Yang C, Feng K, et al. p75NTR enhances cognitive dysfunction in a mouse Alzheimer’s disease model by inhibiting microRNA-210-3p-mediated PCYT2 through activation of NF-κB. Int J Biol Macromol. 2023;225:404–415. doi:10.1016/j.ijbiomac.2022.11.078
   PubMed Web of Science ®Google Scholar
• Li P, Xu Y, Wang B, Huang J, Li Q. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1. J Neurol Sci. 2020;413:116793. doi:10.1016/j.jns.2020.116793
   PubMed Web of Science ®Google Scholar
• Li X, Zhang J, Yang Y, Wu Q, Ning H. MicroRNA-340-5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer’s disease in mice. Cell Biol Int. 2021;45(6):1306–1315. doi:10.1002/cbin.11576
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Liu P, et al. MicroRNA-128 knockout inhibits the development of Alzheimer’s disease by targeting PPARγ in mouse models. Eur J Pharmacol. 2019;843:134–144. doi:10.1016/j.ejphar.2018.11.004
   PubMed Web of Science ®Google Scholar
• Morris G, Berk M, Maes M, Puri BK. Could Alzheimer’s Disease Originate in the Periphery and If So How So. Mol Neurobiol. 2019;56(1):406–434. doi:10.1007/s12035-018-1092-y
   PubMed Web of Science ®Google Scholar
• Chen ML, Hong CG, Yue T, et al. Erratum: Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer’s disease by enhancing autophagy: Erratum. Theranostics. 2021;11(20):9774. doi:10.7150/thno.67227
   PubMed Web of Science ®Google Scholar
• Wan W, Liu G, Li X, et al. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease. Bioengineered. 2021;12(2):12678–12690. doi:10.1080/21655979.2021.2008638
   PubMed Web of Science ®Google Scholar
• Swarup V, Hinz FI, Rexach JE, et al. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat Med. 2019;25(1):152–164. doi:10.1038/s41591-018-0223-3
   PubMed Web of Science ®Google Scholar
• Ghiam S, Eslahchi C, Shahpasand K, Habibi-Rezaei M, Gharaghani S. Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease. Front Aging Neurosci. 2022;14:955461. doi:10.3389/fnagi.2022.955461
   PubMed Web of Science ®Google Scholar
• Xing H, Guo S, Zhang Y, Zheng Z, Wang H. Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia. Mol Med Rep. 2016;14(2):1357–1364. doi:10.3892/mmr.2016.5369
   PubMed Web of Science ®Google Scholar
• Zhao H, Wang J, Gao L, et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke. 2013;44(6):1706–1713. doi:10.1161/STROKEAHA.111.000504
   PubMed Web of Science ®Google Scholar
• Li F, Xie XY, Sui XF, Wang P, Chen Z, Zhang JB. Profile of pathogenic proteins and MicroRNAs in plasma-derived extracellular vesicles in Alzheimer’s disease: a Pilot Study. Neuroscience. 2020;432:240–246. doi:10.1016/j.neuroscience.2020.02.044
   PubMed Web of Science ®Google Scholar
• Tian F, Yuan C, Hu L, Shan S. MicroRNA-93 inhibits inflammatory responses and cell apoptosis after cerebral ischemia reperfusion by targeting interleukin-1 receptor-associated kinase 4. Exp Ther Med. 2017;14(4):2903–2910. doi:10.3892/etm.2017.4874
   PubMed Web of Science ®Google Scholar
• Ghasemi-Kasman M, Shojaei A, Gol M, Moghadamnia AA, Baharvand H, Javan M. miR-302/367-induced neurons reduce behavioral impairment in an experimental model of Alzheimer’s disease. Mol Cell Neurosci. 2018;86:50–57. doi:10.1016/j.mcn.2017.11.012
   PubMed Web of Science ®Google Scholar
• Yuan B, Shen H, Lin L, Su T, Zhong L, Yang Z. MicroRNA367 negatively regulates the inflammatory response of microglia by targeting IRAK4 in intracerebral hemorrhage. J Neuroinflammation. 2015;12(1):206. doi:10.1186/s12974-015-0424-3
   PubMedGoogle Scholar
• Tao W, Yu L, Shu S, et al. miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer’s Disease. Mol Ther. 2021;29(1):396–408. doi:10.1016/j.ymthe.2020.09.006
   PubMed Web of Science ®Google Scholar
• Niranjan R. Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration. Neurochem Int. 2018;120:13–20. doi:10.1016/j.neuint.2018.07.003
   PubMed Web of Science ®Google Scholar
• Yan T, Zhang F, Sun C, et al. miR-32-5p-mediated Dusp5 downregulation contributes to neuropathic pain. Biochem Biophys Res Commun. 2018;495(1):506–511. doi:10.1016/j.bbrc.2017.11.013
   PubMed Web of Science ®Google Scholar
• Xie X, Peng L, Zhu J, et al. miR-145-5p/Nurr1/TNF-α Signaling-Induced Microglia Activation Regulates Neuron Injury of Acute Cerebral Ischemic/Reperfusion in Rats. Front Mol Neurosci. 2017;10:383. doi:10.3389/fnmol.2017.00383
   PubMed Web of Science ®Google Scholar
• Tufekci KU, Ercan I, Isci KB, et al. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol Lett. 2021;233:20–30. doi:10.1016/j.imlet.2021.03.004
   PubMed Web of Science ®Google Scholar
• Rastogi M, Singh SK. Japanese Encephalitis Virus exploits microRNA-155 to suppress the non-canonical NF-κB pathway in human microglial cells. Biochim Biophys Acta Gene Regul Mech. 2020;1863(11):194639. doi:10.1016/j.bbagrm.2020.194639
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007;104(5):1604–1609. doi:10.1073/pnas.0610731104
   PubMed Web of Science ®Google Scholar
• Pedersen IM, Otero D, Kao E, et al. Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med. 2009;1(5):288–295. doi:10.1002/emmm.200900028
   PubMed Web of Science ®Google Scholar
• Guedes J, Cardoso AL, Pedroso de Lima MC. Involvement of microRNA in microglia-mediated immune response. Clin Dev Immunol. 2013;2013:186872. doi:10.1155/2013/186872
   PubMedGoogle Scholar
• Teter B, Morihara T, Lim GP, et al. Curcumin restores innate immune Alzheimer’s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiol Dis. 2019;127:432–448. doi:10.1016/j.nbd.2019.02.015
   PubMed Web of Science ®Google Scholar
• Quinn SR, O’Neill LA. A trio of microRNAs that control Toll-like receptor signalling. Int Immunol. 2011;23(7):421–425. doi:10.1093/intimm/dxr034
   PubMed Web of Science ®Google Scholar
• Liu D, Zhao D, Zhao Y, Wang Y, Zhao Y, Wen C. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation. Curr Alzheimer Res. 2019;16(6):473–482. doi:10.2174/1567205016666190503145207
   PubMed Web of Science ®Google Scholar
• Aloi MS, Prater KE, Sopher B, Davidson S, Jayadev S, Garden GA. The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid1-42 catabolism by microglia. Glia. 2021;69(7):1736–1748. doi:10.1002/glia.23988
   PubMed Web of Science ®Google Scholar
• Martin NA, Hyrlov KH, Elkjaer ML, et al. Absence of miRNA-146a Differentially Alters Microglia Function and Proteome. Front Immunol. 2020;11:1110. doi:10.3389/fimmu.2020.01110
   PubMed Web of Science ®Google Scholar
• Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem. 2008;283(46):31315–31322. doi:10.1074/jbc.M805371200
   PubMed Web of Science ®Google Scholar
• Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans. 2008;36(Pt 6):1211–1215. doi:10.1042/BST0361211
   PubMedGoogle Scholar
• Yang J, Malone F, Go M, et al. Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer’s Risk Genes Via Suppression of TLR4 Signaling. J Mol Neurosci. 2021;71(6):1245–1255. doi:10.1007/s12031-020-01750-1
   PubMed Web of Science ®Google Scholar
• Mai H, Fan W, Wang Y, et al. Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model. Mol Ther Nucleic Acids. 2019;18:681–695. doi:10.1016/j.omtn.2019.10.002
   PubMedGoogle Scholar
• Jayadev S, Case A, Alajajian B, Eastman AJ, Möller T, Garden GA. Presenilin 2 influences miR146 level and activity in microglia. J Neurochem. 2013;127(5):592–599. doi:10.1111/jnc.12400
   PubMed Web of Science ®Google Scholar
• Gaudet AD, Fonken LK, Watkins LR, Nelson RJ, Popovich PG. MicroRNAs: Roles in Regulating Neuroinflammation. Neuroscientist. 2018;24(3):221–245. doi:10.1177/1073858417721150
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Guedes JR, de Lima MC. Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions. Curr Opin Pharmacol. 2016;26:1–9. doi:10.1016/j.coph.2015.09.001
   PubMed Web of Science ®Google Scholar
• Fernandes A, Ribeiro AR, Monteiro M, Garcia G, Vaz AR, Brites D. Secretome from SH-SY5Y APPSwe cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling. Biochimie. 2018;155:67–82. doi:10.1016/j.biochi.2018.05.015
   PubMed Web of Science ®Google Scholar
• Caldeira C, Cunha C, Vaz AR, et al. Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation. Front Aging Neurosci. 2017;9:277. doi:10.3389/fnagi.2017.00277
   PubMed Web of Science ®Google Scholar
• Cieślik M, Czapski GA, Wójtowicz S, et al. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer’s Disease. Mol Neurobiol. 2020;57(3):1374–1388. doi:10.1007/s12035-019-01819-y
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dass J. Study of pathway cross-talk interactions with NF-κB leading to its activation via ubiquitination or phosphorylation: A brief review. Gene. 2016;584(1):97–109. doi:10.1016/j.gene.2016.03.008
   PubMed Web of Science ®Google Scholar
• Strickson S, Emmerich CH, Goh E, et al. Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling. Proc Natl Acad Sci U S A. 2017;114(17):E3481–E3489. doi:10.1073/pnas.1702367114
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang L. Inflamma-MicroRNAs in Alzheimer’s disease: from disease pathogenesis to therapeutic potentials. Front Cell Neurosci. 2021;15:785433. doi:10.3389/fncel.2021.785433
   PubMed Web of Science ®Google Scholar
• Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer’s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol. 2014;50(1):97–106. doi:10.1007/s12035-013-8595-3
   PubMed Web of Science ®Google Scholar
• Wei H, Xu Y, Xu W, et al. Serum Exosomal miR-223 Serves as a Potential Diagnostic and Prognostic Biomarker for Dementia. Neuroscience. 2018;379:167–176. doi:10.1016/j.neuroscience.2018.03.016
   PubMed Web of Science ®Google Scholar
• Aharon A, Spector P, Ahmad RS, et al. Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression. Mol Neurobiol. 2020;57(10):4156–4169. doi:10.1007/s12035-020-02013-1
   PubMed Web of Science ®Google Scholar
• Pan Q, Ma J, Guo K. miR-223 Enhances the Neuroprotection of Estradiol Against Oxidative Stress Injury by Inhibiting the FOXO3/TXNIP Axis. Neurochem Res. 2022;47(7):1865–1877. doi:10.1007/s11064-021-03490-z
   PubMed Web of Science ®Google Scholar
• Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y. Correction: mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis. 2020;11(6):431. doi:10.1038/s41419-020-2583-0
   PubMed Web of Science ®Google Scholar
• Neuner SM, Ding S, Kaczorowski CC. Knockdown of heterochromatin protein 1 binding protein 3 recapitulates phenotypic, cellular, and molecular features of aging. Aging Cell. 2019;18(1):e12886. doi:10.1111/acel.12886
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Xie F, et al. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer’s Disease Mice by Targeting DYRK1A. Curr Neurovasc Res. 2020;17(3):241–248. doi:10.2174/1567202617666200414142637
   PubMed Web of Science ®Google Scholar
• Chaves J, Machado FT, Almeida MF, Bacovsky TB, Ferrari M. microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing. Neurosci Lett. 2020;714:134541. doi:10.1016/j.neulet.2019.134541
   PubMed Web of Science ®Google Scholar
• Lv M, Yang S, Cai L, Qin LQ, Li BY, Wan Z. Effects of quercetin intervention on cognition function in APP/PS1 Mice was affected by vitamin D status. Mol Nutr Food Res. 2018;62(24):e1800621. doi:10.1002/mnfr.201800621
   PubMed Web of Science ®Google Scholar
• Xie T, Pei Y, Shan P, et al. Identification of miRNA-mRNA Pairs in the Alzheimer’s Disease Expression Profile and Explore the Effect of miR-26a-5p/PTGS2 on Amyloid-β Induced Neurotoxicity in Alzheimer’s Disease Cell Model. Front Aging Neurosci. 2022;14:909222. doi:10.3389/fnagi.2022.909222
   PubMed Web of Science ®Google Scholar
• Li B, Sun H. MiR-26a promotes neurite outgrowth by repressing PTEN expression. Mol Med Rep. 2013;8(2):676–680. doi:10.3892/mmr.2013.1534
   PubMed Web of Science ®Google Scholar
• Sala Frigerio C, Lau P, Salta E, et al. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology. 2013;81(24):2103–2106. doi:10.1212/01.wnl.0000437306.37850.22
   PubMed Web of Science ®Google Scholar
• He L, Chen Z, Wang J, Feng H. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer’s disease. BMC Neurol. 2022;22(1):203. doi:10.1186/s12883-022-02728-9
   PubMed Web of Science ®Google Scholar
• Su L, Li R, Zhang Z, Liu J, Du J, Wei H. Identification of altered exosomal microRNAs and mRNAs in Alzheimer’s disease. Ageing Res Rev. 2022;73:101497. doi:10.1016/j.arr.2021.101497
   PubMed Web of Science ®Google Scholar
• Dong LX, Zhang YY, Bao HL, Liu Y, Zhang GW, An FM. LncRNA NEAT1 promotes Alzheimer’s disease by down regulating micro-27a-3p. Am J Transl Res. 2021;13(8):8885–8896.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wu L, Jiang L, et al. Notoginsenoside R2 reduces Aβ25-35-induced neuronal apoptosis and inflammation via miR-27a/SOX8/β-catenin axis. Hum Exp Toxicol. 2021;40(12_suppl):S347–S358. doi:10.1177/09603271211041996
   PubMed Web of Science ®Google Scholar
• Zhang L, Li YJ, Wu XY, Hong Z, Wei WS. MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4. J Neurochem. 2015;132(6):713–723. doi:10.1111/jnc.13021
   PubMed Web of Science ®Google Scholar
• Hutchison ER, Kawamoto EM, Taub DD, et al. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia. 2013;61(7):1018–1028. doi:10.1002/glia.22483
   PubMed Web of Science ®Google Scholar
• Siedlecki-Wullich D, Català-Solsona J, Fábregas C, et al. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease. Alzheimers Res Ther. 2019;11(1):46. doi:10.1186/s13195-019-0501-4
   PubMedGoogle Scholar
• Mankhong S, Kim S, Moon S, et al. Circulating micro-RNAs differentially expressed in Korean Alzheimer’s patients with brain Aβ accumulation activate amyloidogenesis. J Gerontol A Biol Sci Med Sci. 2022. doi:10.1093/gerona/glac106
   Web of Science ®Google Scholar
• Parisi C, Napoli G, Amadio S, et al. MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ. 2016;23(3):531–541. doi:10.1038/cdd.2015.153
   PubMed Web of Science ®Google Scholar
• Tan L, Yu JT, Liu QY, et al. Circulating miR-125b as a biomarker of Alzheimer’s disease. J Neurol Sci. 2014;336(1–2):52–56. doi:10.1016/j.jns.2013.10.002
   PubMed Web of Science ®Google Scholar
• Hong H, Li Y, Su B. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer’s Disease in APP/PS1 Transgenic Mouse. J Alzheimers Dis. 2017;59(4):1449–1458. doi:10.3233/JAD-170156
   PubMed Web of Science ®Google Scholar
• Tang H, Ma M, Wu Y, et al. Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer’s disease via C/EBPα/miR-125b pathway. Aging Cell. 2019;18(2):e12902. doi:10.1111/acel.12902
   PubMed Web of Science ®Google Scholar
• Micheli F, Palermo R, Talora C, Ferretti E, Vacca A, Napolitano M. Regulation of proapoptotic proteins Bak1 and p53 by miR-125b in an experimental model of Alzheimer’s disease: protective role of 17β-estradiol. Neurosci Lett. 2016;629:234–240. doi:10.1016/j.neulet.2016.05.049
   PubMed Web of Science ®Google Scholar
• Dobricic V, Schilling M, Schulz J, et al. Differential microRNA expression analyses across two brain regions in Alzheimer’s disease. Transl Psychiatry. 2022;12(1):352. doi:10.1038/s41398-022-02108-4
   PubMed Web of Science ®Google Scholar
• Qian Z, Chang J, Jiang F, et al. Excess administration of miR-340-5p ameliorates spinal cord injury-induced neuroinflammation and apoptosis by modulating the P38-MAPK signaling pathway. Brain Behav Immun. 2020;87:531–542. doi:10.1016/j.bbi.2020.01.025
   PubMed Web of Science ®Google Scholar
• Tan X, Luo Y, Pi D, Xia L, Li Z, Tu Q. MiR-340 reduces the accumulation of amyloid-β through targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer’s disease. Curr Neurovasc Res. 2020;17(1):86–92. doi:10.2174/1567202617666200117103931
   PubMed Web of Science ®Google Scholar
• Yang Z, Xu J, Zhu R, Liu L. Down-Regulation of miRNA-128 Contributes to Neuropathic Pain Following Spinal Cord Injury via Activation of P38. Med Sci Monit. 2017;23:405–411. doi:10.12659/msm.898788
   PubMed Web of Science ®Google Scholar
• Zhang M, Han W, Xu Y, Li D, Xue Q. Serum miR-128 serves as a potential diagnostic biomarker for Alzheimer’s disease. Neuropsychiatr Dis Treat. 2021;17:269–275. doi:10.2147/NDT.S290925
   PubMed Web of Science ®Google Scholar
• Geng L, Zhang T, Liu W, Chen Y. Inhibition of miR-128 Abates Aβ-Mediated Cytotoxicity by Targeting PPAR-γ via NF-κB Inactivation in Primary Mouse Cortical Neurons and Neuro2a Cells. Yonsei Med J. 2018;59(9):1096–1106. doi:10.3349/ymj.2018.59.9.1096
   PubMed Web of Science ®Google Scholar
• Deng M, Zhang Q, Wu Z, et al. Mossy cell synaptic dysfunction causes memory imprecision via miR-128 inhibition of STIM2 in Alzheimer’s disease mouse model. Aging Cell. 2020;19(5):e13144. doi:10.1111/acel.13144
   PubMed Web of Science ®Google Scholar
• Shvarts-Serebro I, Sheinin A, Gottfried I, et al. miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons. J Mol Neurosci. 2021;71(12):2593–2607. doi:10.1007/s12031-021-01862-2
   PubMed Web of Science ®Google Scholar
• Nguyen T, Kumar M, Fedele E, Bonanno G, Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int J Mol Sci. 2022;23(9). doi:10.3390/ijms23094718
   Web of Science ®Google Scholar
• Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging. 2012;4(9):590–605. doi:10.18632/aging.100486
   PubMedGoogle Scholar
• Song Y, Li Z, He T, et al. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics. 2019;9(10):2910–2923. doi:10.7150/thno.30879
   PubMed Web of Science ®Google Scholar
• Hamzei Taj S, Kho W, Riou A, Wiedermann D, Hoehn M. MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials. 2016;91:151–165. doi:10.1016/j.biomaterials.2016.03.025
   PubMed Web of Science ®Google Scholar
• Jiang D, Gong F, Ge X, et al. Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnology. 2020;18(1):105. doi:10.1186/s12951-020-00665-8
   PubMed Web of Science ®Google Scholar
• Guo ML, Periyasamy P, Liao K, et al. Cocaine-mediated downregulation of microglial miR-124 expression involves promoter DNA methylation. Epigenetics. 2016;11(11):819–830. doi:10.1080/15592294.2016.1232233
   PubMed Web of Science ®Google Scholar
• Garcia G, Fernandes A, Stein F, Brites D. Protective Signature of IFNγ-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells. Front Pharmacol. 2022;13:833066. doi:10.3389/fphar.2022.833066
   PubMed Web of Science ®Google Scholar
• Mastroeni D, Sekar S, Nolz J, et al. Correction: ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity. PLoS One. 2018;13(1):e0191382. doi:10.1371/journal.pone.0191382
   PubMed Web of Science ®Google Scholar
• Chen ML, Hong CG, Yue T, et al. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer’s disease by enhancing autophagy. Theranostics. 2021;11(5):2395–2409. doi:10.7150/thno.47408
   PubMed Web of Science ®Google Scholar
• Yang L, Chao J, Kook YH, Gao Y, Yao H, Buch SJ. Involvement of miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell Death Dis. 2013;4:e960. doi:10.1038/cddis.2013.486
   PubMed Web of Science ®Google Scholar
• Yao H, Ma R, Yang L, et al. MiR-9 promotes microglial activation by targeting MCPIP1. Nat Commun. 2014;5:4386. doi:10.1038/ncomms5386
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhong L, Zhong S, Xian R, Yuan B. miR-203 protects microglia mediated brain injury by regulating inflammatory responses via feedback to MyD88 in ischemia. Mol Immunol. 2015;65(2):293–301. doi:10.1016/j.molimm.2015.01.019
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Wang LQ, Xu QS, et al. Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells. Exp Cell Res. 2016;349(1):60–67. doi:10.1016/j.yexcr.2016.09.020
   PubMed Web of Science ®Google Scholar
• McNay EC, Pearson-Leary J. GluT4: A central player in hippocampal memory and brain insulin resistance. Exp Neurol. 2020;323:113076. doi:10.1016/j.expneurol.2019.113076
   PubMed Web of Science ®Google Scholar
• Mathew B, Acha LG, Torres LA, et al. MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: engineered extracellular vesicles and retinal ischemia. Acta Biomater. 2023;158:782–797. doi:10.1016/j.actbio.2023.01.014
   PubMed Web of Science ®Google Scholar
• Li L, Sun Q, Li Y, et al. Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia. J Mol Neurosci. 2015;56(4):858–867. doi:10.1007/s12031-015-0526-5
   PubMed Web of Science ®Google Scholar
• Raden M, Wallach T, Miladi M, et al. Structure-aware machine learning identifies microRNAs operating as Toll-like receptor 7/8 ligands. RNA Biol. 2021;18(sup1):268–277. doi:10.1080/15476286.2021.1940697
   PubMedGoogle Scholar
• Markoutsa E, Mayilsamy K, Gulick D, Mohapatra SS, Mohapatra S. Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation-implication of miRNAs. Mol Ther. 2022;30(2):816–830. doi:10.1016/j.ymthe.2021.08.008
   PubMedGoogle Scholar
• Brites D. Regulatory function of microRNAs in microglia. Glia. 2020;68(8):1631–1642. doi:10.1002/glia.23846
   PubMed Web of Science ®Google Scholar
• Ponomarev ED, Veremeyko T, Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia. 2013;61(1):91–103. doi:10.1002/glia.22363
   PubMed Web of Science ®Google Scholar
• Fernandes A, Caldeira C, Cunha C, Ferreiro E, Vaz AR, Brites D. Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice. Cells. 2022;11(1). doi:10.3390/cells11010137
   Web of Science ®Google Scholar
• Lin X, Wang R, Li R, Tao T, Zhang D, Qi Y. Diagnostic Performance of miR-485-3p in Patients with Parkinson’s Disease and its Relationship with Neuroinflammation. Neuromolecular Med. 2022;24(2):195–201. doi:10.1007/s12017-021-08676-w
   PubMed Web of Science ®Google Scholar
• Konovalova J, Gerasymchuk D, Parkkinen I, Chmielarz P, Domanskyi A. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases. Int J Mol Sci. 2019;20(23). doi:10.3390/ijms20236055
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yi P, Yi M, et al. Protective effect of quercetin against H2O2-induced oxidative damage in PC-12 Cells: comprehensive analysis of a lncRNA-associated ceRNA network. Oxid Med Cell Longev. 2020;2020:6038919. doi:10.1155/2020/6038919
   PubMed Web of Science ®Google Scholar
• Chen M, Li L, Liu C, Song L. Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer’s disease. Mol Cell Biochem. 2020;474(1–2):285–294. doi:10.1007/s11010-020-03852-1
   PubMed Web of Science ®Google Scholar
• Falcão AS, Carvalho LA, Lidónio G, et al. Dipeptidyl Vinyl Sulfone as a novel chemical tool to inhibit HMGB1/NLRP3-inflammasome and Inflamma-miRs in Aβ-mediated microglial inflammation. ACS Chem Neurosci. 2017;8(1):89–99. doi:10.1021/acschemneuro.6b00250
   PubMed Web of Science ®Google Scholar
• Amjad N, Yang R, Li L, et al. Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced Neuroinflammation via TNFAIP3-Mediated NF-κB Inhibition. Pathogens. 2019;8(4). doi:10.3390/pathogens8040268
   Web of Science ®Google Scholar
• Paschon V, Takada SH, Ikebara JM, et al. Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders. Mol Neurobiol. 2016;53(3):2016–2028. doi:10.1007/s12035-015-9142-1
   PubMed Web of Science ®Google Scholar
• Borbet TC, Hines MJ, Koralov SB. MicroRNA regulation of B cell receptor signaling. Immunol Rev. 2021;304(1):111–125. doi:10.1111/imr.13024
   PubMed Web of Science ®Google Scholar
• Zhang M, Ye Y, Cong J, et al. Regulation of STAT3 by miR-106a is linked to cognitive impairment in ovariectomized mice. Brain Res. 2013;1503:43–52. doi:10.1016/j.brainres.2013.01.052
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted L, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Panda AC, Munk R, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017;14(3):361–369. doi:10.1080/15476286.2017.1279788
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6):2846–2858. doi:10.1093/nar/gkw027
   PubMed Web of Science ®Google Scholar
• Hanan M, Soreq H, Kadener S. CircRNAs in the brain. RNA Biol. 2017;14(8):1028–1034. doi:10.1080/15476286.2016.1255398
   PubMed Web of Science ®Google Scholar
• Li R, Jiang J, Shi H, Qian H, Zhang X, Xu W. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77(9):1661–1680. doi:10.1007/s00018-019-03345-5
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. doi:10.1186/s12943-017-0663-2
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A, Stottmeister C, Glažar P, et al. Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015;58(5):870–885. doi:10.1016/j.molcel.2015.03.027
   PubMed Web of Science ®Google Scholar
• Curry-Hyde A, Gray L, Chen BJ, Ueberham U, Arendt T, Janitz M. Cell type-specific circular RNA expression in human glial cells. Genomics. 2020. doi:10.1016/j.ygeno.2020.09.042
   Google Scholar
• Wu T, Li Y, Liang X, Liu X, Tang M. Identification of potential circRNA-miRNA-mRNA regulatory networks in response to graphene quantum dots in microglia by microarray analysis. Ecotoxicol Environ Saf. 2021;208:111672. doi:10.1016/j.ecoenv.2020.111672
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao J, Xu J, et al. Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2. Oncogene. 2022;41(26):3461–3473. doi:10.1038/s41388-022-02360-4
   PubMed Web of Science ®Google Scholar
• Jiang F, Liu X, Cui X, et al. Circ_0000518 Promotes Macrophage/Microglia M1 Polarization via the FUS/CaMKKβ/AMPK Pathway to Aggravate Multiple Sclerosis. Neuroscience. 2022;490:131–143. doi:10.1016/j.neuroscience.2021.12.012
   PubMed Web of Science ®Google Scholar
• Xiaoying G, Guo M, Jie L, et al. CircHivep2 contributes to microglia activation and inflammation via miR-181a-5p/SOCS2 signalling in mice with kainic acid-induced epileptic seizures. J Cell Mol Med. 2020. doi:10.1111/jcmm.15894
   PubMed Web of Science ®Google Scholar
• Li M, Hu J, Peng Y, Li J, Ren R. CircPTK2-miR-181c-5p-HMGB1: a new regulatory pathway for microglia activation and hippocampal neuronal apoptosis induced by sepsis. Mol Med. 2021;27(1):45. doi:10.1186/s10020-021-00305-3
   PubMed Web of Science ®Google Scholar
• Liu H, Jin M, Ji M, Zhang W, Liu A, Wang T. Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer’s disease mice model. Aging. 2022;14(7):3070–3083. doi:10.18632/aging.203989
   PubMedGoogle Scholar
• Urdánoz-Casado A, de Gordoa JS, Robles M, et al. Profile of TREM2-Derived circRNA and mRNA Variants in the Entorhinal Cortex of Alzheimer’s Disease Patients. Int J Mol Sci. 2022;23(14). doi:10.3390/ijms23147682
   PubMed Web of Science ®Google Scholar
• Li N, Zhang D, Guo H, Yang Q, Li P, He Y. Inhibition of circ_0004381 improves cognitive function via miR-647/PSEN1 axis in an Alzheimer disease mouse model. J Neuropathol Exp Neurol. 2022;82(1):84–92. doi:10.1093/jnen/nlac108
   PubMed Web of Science ®Google Scholar
• Akhter R. Circular RNA and Alzheimer’s Disease. Adv Exp Med Biol. 2018;1087:239–243. doi:10.1007/978-981-13-1426-1_19
   PubMed Web of Science ®Google Scholar
• Xu X, Gu D, Xu B, Yang C, Wang L. Circular RNA circ_0005835 promotes promoted neural stem cells proliferation and differentiate to neuron and inhibits inflammatory cytokines levels through miR-576-3p in Alzheimer’s disease. Environ Sci Pollut Res Int. 2022;29(24):35934–35943. doi:10.1007/s11356-021-17478-3
   PubMed Web of Science ®Google Scholar
• Wang H, Li Z, Gao J, Liao Q. Circular RNA circPTK2 regulates oxygen-glucose deprivation-activated microglia-induced hippocampal neuronal apoptosis via miR-29b-SOCS-1-JAK2/STAT3-IL-1β signaling. Int J Biol Macromol. 2019;129:488–496. doi:10.1016/j.ijbiomac.2019.02.041
   PubMed Web of Science ®Google Scholar
• Li Y, Han X, Fan H, et al. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer’s disease. Neurosci Lett. 2022;776:136531. doi:10.1016/j.neulet.2022.136531
   PubMed Web of Science ®Google Scholar
• Chen HH, Eteleeb A, Wang C, et al. Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer’s disease. Acta Neuropathol Commun. 2022;10(1):29. doi:10.1186/s40478-022-01328-5
   PubMed Web of Science ®Google Scholar
• Ren Z, Chu C, Pang Y, Cai H, Jia L. A circular RNA blood panel that differentiates Alzheimer’s disease from other dementia types. Biomark Res. 2022;10(1):63. doi:10.1186/s40364-022-00405-0
   PubMed Web of Science ®Google Scholar
• Piscopo P, Manzini V, Rivabene R, et al. A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls. Int J Mol Sci. 2022;23(21). doi:10.3390/ijms232113232
   Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915–1927. doi:10.1101/gad.17446611
   PubMed Web of Science ®Google Scholar
• Clark BS, Blackshaw S. Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease. Front Genet. 2014;5:164. doi:10.3389/fgene.2014.00164
   PubMed Web of Science ®Google Scholar
• Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116. doi:10.1093/bib/bbv031
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zheng LL, et al. Discovery of Protein-lncRNA Interactions by Integrating Large-Scale CLIP-Seq and RNA-Seq Datasets. Front Bioeng Biotechnol. 2014;2:88. doi:10.3389/fbioe.2014.00088
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286. doi:10.1007/978-1-4939-3378-5_21
   PubMedGoogle Scholar
• Gao X, Cao Z, Tan H, et al. LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization. Front Neurosci. 2022;16:903472. doi:10.3389/fnins.2022.903472
   PubMed Web of Science ®Google Scholar
• Feng X, Zhan F, Luo D, et al. LncRNA 4344 promotes NLRP3-related neuroinflammation and cognitive impairment by targeting miR-138-5p. Brain Behav Immun. 2021;98:283–298. doi:10.1016/j.bbi.2021.08.230
   PubMed Web of Science ®Google Scholar
• Xue Z, Zhang Z, Liu H, et al. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death Differ. 2019;26(1):130–145. doi:10.1038/s41418-018-0105-8
   PubMed Web of Science ®Google Scholar
• Jing W, Tuxiu X, Xiaobing L, et al. LncRNA GAS5/miR-137 Is a Hypoxia-Responsive Axis Involved in Cardiac Arrest and Cardiopulmonary Cerebral Resuscitation. Front Immunol. 2021;12:790750. doi:10.3389/fimmu.2021.790750
   PubMed Web of Science ®Google Scholar
• Zhang YY, Bao HL, Dong LX, Liu Y, Zhang GW, An FM. Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer’s disease. Cell Cycle. 2021;20(1):112–125. doi:10.1080/15384101.2020.1863681
   PubMed Web of Science ®Google Scholar
• Li L, Xu Y, Zhao M, Gao Z. Neuro-protective roles of long non-coding RNA MALAT1 in Alzheimer’s disease with the involvement of the microRNA-30b/CNR1 network and the following PI3K/AKT activation. Exp Mol Pathol. 2020;117:104545. doi:10.1016/j.yexmp.2020.104545
   PubMed Web of Science ®Google Scholar
• Lu J, Liu L, Chen J, et al. The Involvement of lncRNA HOTAIR/miR-130a-3p Axis in the Regulation of Voluntary Exercise on Cognition and Inflammation of Alzheimer’s Disease. Am J Alzheimers Dis Other Demen. 2022;37:15333175221091424. doi:10.1177/15333175221091424
   Web of Science ®Google Scholar
• Duan R, Wang SY, Wei B, et al. Angiotensin-(1-7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14/miR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer’s Disease. J Inflamm Res. 2021;14:7007–7019. doi:10.2147/JIR.S343575
   PubMed Web of Science ®Google Scholar
• Cai M, Wang YW, Xu SH, et al. Regulatory effects of the long non‑coding RNA RP11‑543N12.1 and microRNA‑324‑3p axis on the neuronal apoptosis induced by the inflammatory reactions of microglia. Int J Mol Med. 2018;42(3):1741–1755. doi:10.3892/ijmm.2018.3736
   PubMed Web of Science ®Google Scholar
• Yue D, Guanqun G, Jingxin L, et al. Silencing of long noncoding RNA XIST attenuated Alzheimer’s disease-related BACE1 alteration through miR-124. Cell Biol Int. 2020;44(2):630–636. doi:10.1002/cbin.11263
   PubMed Web of Science ®Google Scholar
• Qin YR, Ma CQ, Wang DP, et al. Bilobalide alleviates neuroinflammation and promotes autophagy in Alzheimer’s disease by upregulating lincRNA-p21. Am J Transl Res. 2021;13(4):2021–2040.
   PubMed Web of Science ®Google Scholar
• Hu G, Gong AY, Wang Y, et al. LincRNA-Cox2 Promotes Late Inflammatory Gene Transcription in Macrophages through Modulating SWI/SNF-Mediated Chromatin Remodeling. J Immunol. 2016;196(6):2799–2808. doi:10.4049/jimmunol.1502146
   PubMed Web of Science ®Google Scholar
• Sun D, Yu Z, Fang X, et al. LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Rep. 2017;18(10):1801–1816. doi:10.15252/embr.201643668
   PubMed Web of Science ®Google Scholar
• Chen X, Ren G, Li Y, et al. Level of LncRNA GAS5 and hippocampal volume are associated with the progression of Alzheimer’s disease. Clin Interv Aging. 2022;17:745–753. doi:10.2147/CIA.S363116
   PubMed Web of Science ®Google Scholar
• Xu W, Zhang L, Geng Y, Liu Y, Zhang N. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson’s disease by regulating NLRP3 pathway through sponging miR-223-3p. Int Immunopharmacol. 2020;85:106614. doi:10.1016/j.intimp.2020.106614
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu M, Zhang X, et al. Isosteviol Sodium Protects against Ischemic Stroke by Modulating Microglia/Macrophage Polarization via Disruption of GAS5/miR-146a-5p sponge. Sci Rep. 2019;9(1):12221. doi:10.1038/s41598-019-48759-0
   PubMedGoogle Scholar
• Jiang Z, Liu M, Huang D, Cai Y, Zhou Y. Silencing of long noncoding RNA GAS5 blocks experimental cerebral ischemia-reperfusion injury by restraining AQP4 expression via the miR-1192/STAT5A axis. Mol Neurobiol. 2022;59(12):7450–7465. doi:10.1007/s12035-022-03045-5
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang Z, Wang H. Downregulation of lncRNA GAS5 prevents mitochondrial apoptosis and hypoxic-ischemic brain damage in neonatal rats through the microRNA-128-3p/Bax/Akt/GSK-3β axis. Neuroreport. 2021;32(17):1395–1402. doi:10.1097/WNR.0000000000001730
   PubMed Web of Science ®Google Scholar
• Han Y, Wu N, Xia F, Liu S, Jia D. Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p. Int J Mol Med. 2020;45(3):858–872. doi:10.3892/ijmm.2020.4471
   PubMed Web of Science ®Google Scholar
• Wu Y, Rong W, Jiang Q, Wang R, Huang H. Downregulation of lncRNA GAS5 Alleviates Hippocampal Neuronal Damage in Mice with Depression-Like Behaviors Via Modulation of MicroRNA-26a/EGR1 Axis. J Stroke Cerebrovasc Dis. 2021;30(3):105550. doi:10.1016/j.jstrokecerebrovasdis.2020.105550
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang L, Wang E, Zhang C, Li X. LncRNA GAS5 regulates ischemic stroke as a competing endogenous RNA for miR-137 to regulate the Notch1 signaling pathway. Biochem Biophys Res Commun. 2018;496(1):184–190. doi:10.1016/j.bbrc.2018.01.022
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao H, Fan Z, et al. Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization. Stroke. 2017;48(8):2211–2221. doi:10.1161/STROKEAHA.117.017387
   PubMed Web of Science ®Google Scholar
• Han CL, Ge M, Liu YP, et al. LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy. J Neuroinflammation. 2018;15(1):103. doi:10.1186/s12974-018-1139-z
   PubMed Web of Science ®Google Scholar
• Han CL, Liu YP, Guo CJ, et al. The lncRNA H19 binding to let-7b promotes hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy. Cell Prolif. 2020;53(8):e12856. doi:10.1111/cpr.12856
   PubMed Web of Science ®Google Scholar
• Wang LQ, Zhou HJ. LncRNA MALAT1 promotes high glucose-induced inflammatory response of microglial cells via provoking MyD88/IRAK1/TRAF6 signaling. Sci Rep. 2018;8(1):8346. doi:10.1038/s41598-018-26421-5
   PubMedGoogle Scholar
• Cai LJ, Tu L, Huang XM, et al. LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease. Mol Brain. 2020;13(1):130. doi:10.1186/s13041-020-00656-8
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Wang LQ, Wang DB, et al. Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR-199b/IKKβ/NF-κB signaling pathway. Am J Physiol Cell Physiol. 2018;315(1):C52–C61. doi:10.1152/ajpcell.00278.2017
   PubMed Web of Science ®Google Scholar
• Han D, Zhou Y. YY1-induced upregulation of lncRNA NEAT1 contributes to OGD/R injury-induced inflammatory response in cerebral microglial cells via Wnt/β-catenin signaling pathway. Vitro Cell Dev Biol Anim. 2019;55(7):501–511. doi:10.1007/s11626-019-00375-y
   PubMed Web of Science ®Google Scholar
• Khodayi M, Khalaj-Kondori M, Hoseinpour Feizi MA, Jabarpour Bonyadi M, Talebi M. Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer’s disease. EXCLI J. 2022;21:772–785. doi:10.17179/excli2022-4764
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhao J, Wang W, Zhou J, Zhang J. Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer’s Disease. Front Cell Neurosci. 2020;14:28. doi:10.3389/fncel.2020.00028
   PubMed Web of Science ®Google Scholar
• Cheng S, Zhang Y, Chen S, Zhou Y. LncRNA HOTAIR Participates in Microglia Activation and Inflammatory Factor Release by Regulating the Ubiquitination of MYD88 in Traumatic Brain Injury. J Mol Neurosci. 2020. doi:10.1007/s12031-020-01623-7
   Web of Science ®Google Scholar
• Duan C, Liu Y, Li Y, et al. Sulfasalazine alters microglia phenotype by competing endogenous RNA effect of miR-136-5p and long non-coding RNA HOTAIR in cuprizone-induced demyelination. Biochem Pharmacol. 2018;155:110–123. doi:10.1016/j.bcp.2018.06.028
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao S, Li G, Wang D, Jin Y. Neuroprotective Effect of HOTAIR Silencing on Isoflurane-Induced Cognitive Dysfunction via Sponging microRNA-129-5p and Inhibiting Neuroinflammation. Neuroimmunomodulation. 2022;29(4):369–379. doi:10.1159/000521014
   PubMed Web of Science ®Google Scholar
• Zhao J, Li H, Chang N. LncRNA HOTAIR promotes MPP+-induced neuronal injury in Parkinson’s disease by regulating the miR-874-5p/ATG10 axis. EXCLI J. 2020;19:1141–1153. doi:10.17179/excli2020-2286
   PubMed Web of Science ®Google Scholar
• Lu J, Liu L, Chen J, et al. LncRNA HOTAIR in exercise-induced neuro-protective function in Alzheimer’s disease. Folia Neuropathol. 2022;60(4):414–420. doi:10.5114/fn.2022.118961
   PubMed Web of Science ®Google Scholar
• Qi X, Shao M, Sun H, Shen Y, Meng D, Huo W. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction. Neuroscience. 2017;348:98–106. doi:10.1016/j.neuroscience.2017.02.002
   PubMed Web of Science ®Google Scholar
• Zhao Q, Lu F, Su Q, et al. Knockdown of long noncoding RNA XIST mitigates the apoptosis and inflammatory injury of microglia cells after spinal cord injury through miR-27a/Smurf1 axis. Neurosci Lett. 2020;715:134649. doi:10.1016/j.neulet.2019.134649
   PubMed Web of Science ®Google Scholar
• Xing F, Liu Y, Wu SY, et al. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Res. 2018;78(15):4316–4330. doi:10.1158/0008-5472.CAN-18-1102
   PubMed Web of Science ®Google Scholar
• Yan XW, Liu HJ, Hong YX, Meng T, Du J, Chang C. lncRNA XIST induces Aβ accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer’s disease. J Neurogenet. 2022;36(1):11–20. doi:10.1080/01677063.2022.2028784
   PubMed Web of Science ®Google Scholar
• Ye Y, He X, Lu F, et al. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS- and MPTP- induced neuroinflammation. Cell Death Dis. 2018;9(8):803. doi:10.1038/s41419-018-0821-5
   PubMedGoogle Scholar
• Wang Q, Ge X, Zhang J, Chen L. Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer’s disease via inhibition of the miR-375/SIX4 axis. Aging. 2020;12(23):23974–23995. doi:10.18632/aging.104079
   PubMedGoogle Scholar
• Wen Y, Yu Y, Fu X. LncRNA Gm4419 contributes to OGD/R injury of cerebral microglial cells via IκB phosphorylation and NF-κB activation. Biochem Biophys Res Commun. 2017;487(4):923–929. doi:10.1016/j.bbrc.2017.05.005
   PubMed Web of Science ®Google Scholar
• Pang H, Ren Y, Li H, Chen C, Zheng X. LncRNAs linc00311 and AK141205 are identified as new regulators in STAT3-mediated neuropathic pain in bCCI rats. Eur J Pharmacol. 2020;868:172880. doi:10.1016/j.ejphar.2019.172880
   PubMed Web of Science ®Google Scholar
• Fu CH, Zhang BH, Fang CZ, et al. Long non-coding RNA CRNDE deteriorates intrauterine infection-induced neonatal brain injury. Mol Cell Probes. 2020;52:101565. doi:10.1016/j.mcp.2020.101565
   PubMed Web of Science ®Google Scholar
• Yang X, Chen Y, Li J, et al. Hypertonic saline maintains coagulofibrinolytic homeostasis following moderate‑to‑severe traumatic brain injury by regulating monocyte phenotype via expression of lncRNAs. Mol Med Rep. 2019;19(2):1083–1091. doi:10.3892/mmr.2018.9748
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu XL, Ji BY, et al. LncRNA-1810034E14Rik reduces microglia activation in experimental ischemic stroke. J Neuroinflammation. 2019;16(1):75. doi:10.1186/s12974-019-1464-x
   PubMed Web of Science ®Google Scholar
• Xiang W, Jiang L, Zhou Y, et al. The lncRNA Ftx/miR-382-5p/Nrg1 axis improves the inflammation response of microglia and spinal cord injury repair. Neurochem Int. 2021;143:104929. doi:10.1016/j.neuint.2020.104929
   PubMed Web of Science ®Google Scholar
• Shao M, Jin M, Xu S, et al. Exosomes from Long Noncoding RNA-Gm37494-ADSCs Repair Spinal Cord Injury via Shifting Microglial M1/M2 Polarization. Inflammation. 2020;43(4):1536–1547. doi:10.1007/s10753-020-01230-z
   PubMed Web of Science ®Google Scholar
• Cui SY, Zhang W, Cui ZM, et al. Knockdown of long non-coding RNA LEF1-AS1 attenuates apoptosis and inflammatory injury of microglia cells following spinal cord injury. J Orthop Surg Res. 2021;16(1):6. doi:10.1186/s13018-020-02041-6
   PubMed Web of Science ®Google Scholar
• Xu S, Wang J, Jiang J, et al. TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K/AKT pathway after spinal cord injury. Cell Death Dis. 2020;11(8):693. doi:10.1038/s41419-020-02824-z
   PubMed Web of Science ®Google Scholar
• Wang H, Liao S, Li H, Chen Y, Yu J. Long Non-coding RNA TUG1 Sponges Mir-145a-5p to Regulate Microglial Polarization After Oxygen-Glucose Deprivation. Front Mol Neurosci. 2019;12:215. doi:10.3389/fnmol.2019.00215
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang J, Zheng H, et al. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. J Exp Clin Cancer Res. 2019;38(1):380. doi:10.1186/s13046-019-1371-0
   PubMed Web of Science ®Google Scholar
• Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252–2266. doi:10.1016/j.molcel.2022.05.027
   PubMed Web of Science ®Google Scholar
• Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2). doi:10.1083/jcb.202009045
   PubMed Web of Science ®Google Scholar
• Wang SH, Zhu XL, Wang F, et al. LncRNA H19 governs mitophagy and restores mitochondrial respiration in the heart through Pink1/Parkin signaling during obesity. Cell Death Dis. 2021;12(6):557. doi:10.1038/s41419-021-03821-6
   PubMed Web of Science ®Google Scholar
• Ransohoff RM. A polarizing question: do M1 and M2 microglia exist. Nat Neurosci. 2016;19(8):987–991. doi:10.1038/nn.4338
   PubMed Web of Science ®Google Scholar
• Wendimu MY, Hooks SB. Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells. 2022;11(13). doi:10.3390/cells11132091
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Sierra A, Stevens B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110(21):3458–3483. doi:10.1016/j.neuron.2022.10.020
   PubMed Web of Science ®Google Scholar
• Treiber T, Treiber N, Meister G. Publisher correction: regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20(5):321. doi:10.1038/s41580-019-0106-6
   PubMed Web of Science ®Google Scholar
• Khorkova O, Stahl J, Joji A, Volmar CH, Wahlestedt C. Amplifying gene expression with RNA-targeted therapeutics. Nat Rev Drug Discov. 2023;22(7):539–561. doi:10.1038/s41573-023-00704-7
   PubMed Web of Science ®Google Scholar